145 related articles for article (PubMed ID: 29805635)
1. Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis.
Kanazawa T; Misawa K; Fukushima H; Misawa Y; Sato Y; Maruta M; Imayoshi S; Kusaka G; Kawabata K; Mineta H; Carey TE; Nishino H
Oncol Lett; 2018 Jun; 15(6):9043-9050. PubMed ID: 29805635
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
[TBL] [Abstract][Full Text] [Related]
4. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
[TBL] [Abstract][Full Text] [Related]
5. Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.
Kanazawa T; Kommareddi PK; Iwashita T; Kumar B; Misawa K; Misawa Y; Jang I; Nair TS; Iino Y; Carey TE
Clin Cancer Res; 2009 Apr; 15(7):2222-30. PubMed ID: 19276245
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas.
Kanazawa T; Misawa K; Shinmura K; Misawa Y; Kusaka G; Maruta M; Sasaki T; Watanabe Y; Carey TE
Expert Rev Mol Diagn; 2019 Feb; 19(2):137-148. PubMed ID: 30640567
[TBL] [Abstract][Full Text] [Related]
7. Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.
Kanazawa T; Misawa K; Carey TE
Expert Opin Ther Targets; 2010 Mar; 14(3):289-302. PubMed ID: 20148716
[TBL] [Abstract][Full Text] [Related]
8. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
[TBL] [Abstract][Full Text] [Related]
9. Galanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancer.
Misawa K; Kanazawa T; Misawa Y; Uehara T; Imai A; Takahashi G; Takebayashi S; Cole A; Carey TE; Mineta H
Transl Oncol; 2013 Jun; 6(3):338-46. PubMed ID: 23730414
[TBL] [Abstract][Full Text] [Related]
10. G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
Kanazawa T; Misawa K; Misawa Y; Uehara T; Fukushima H; Kusaka G; Maruta M; Carey TE
Toxins (Basel); 2015 Aug; 7(8):2959-84. PubMed ID: 26251921
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
12. Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.
Kanazawa T; Iwashita T; Kommareddi P; Nair T; Misawa K; Misawa Y; Ueda Y; Tono T; Carey TE
Oncogene; 2007 Aug; 26(39):5762-71. PubMed ID: 17384686
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
[TBL] [Abstract][Full Text] [Related]
14. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors.
Mazarati A; Lu X
Neuropeptides; 2005 Jun; 39(3):277-80. PubMed ID: 15944022
[TBL] [Abstract][Full Text] [Related]
15. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
[TBL] [Abstract][Full Text] [Related]
16. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
[TBL] [Abstract][Full Text] [Related]
18. Evolution of galanin receptor genes: insights from the deuterostome genomes.
Liu Z; Xu Y; Wu L; Zhang S
J Biomol Struct Dyn; 2010 Aug; 28(1):97-106. PubMed ID: 20476798
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.
Kolakowski LF; O'Neill GP; Howard AD; Broussard SR; Sullivan KA; Feighner SD; Sawzdargo M; Nguyen T; Kargman S; Shiao LL; Hreniuk DL; Tan CP; Evans J; Abramovitz M; Chateauneuf A; Coulombe N; Ng G; Johnson MP; Tharian A; Khoshbouei H; George SR; Smith RG; O'Dowd BF
J Neurochem; 1998 Dec; 71(6):2239-51. PubMed ID: 9832121
[TBL] [Abstract][Full Text] [Related]
20. Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells.
Berger A; Lang R; Moritz K; Santic R; Hermann A; Sperl W; Kofler B
Endocrinology; 2004 Feb; 145(2):500-7. PubMed ID: 14592962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
